A 50-year old federal law is making it difficult for states to pay for residential addiction treatment through Medicaid. The provision, known as the Institute for Mental Disease or IMD exclusion, limits the size of residential treatment programs covered by Medicaid and as a result significantly reduces access to care. The New York Times recently published an excellent analysis of the issue including details about how the IMD exclusion limits new addiction benefits now available under the Affordable Care Act.